| Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of oncology 30 (8), 1194-1220, 2019 | 2329 | 2019 |
| Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016 | 964 | 2016 |
| Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ... Annals of oncology 29, iv238-iv255, 2018 | 895 | 2018 |
| Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up G Argilés, J Tabernero, R Labianca, D Hochhauser, R Salazar, T Iveson, ... Annals of Oncology 31 (10), 1291-1305, 2020 | 829 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 739 | 2021 |
| Dose-and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors J Tabernero, F Rojo, E Calvo, H Burris, I Judson, K Hazell, E Martinelli, ... Journal of Clinical Oncology 26 (10), 1603-1610, 2008 | 643 | 2008 |
| Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ A Cervantes, R Adam, S Roselló, D Arnold, N Normanno, J Taïeb, ... Annals of Oncology 34 (1), 10-32, 2023 | 516 | 2023 |
| Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy E Martinelli, R De Palma, M Orditura, F De Vita, F Ciardiello Clinical & Experimental Immunology 158 (1), 1-9, 2009 | 399 | 2009 |
| Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines A Vogel, E Martinelli, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, ... Annals of Oncology 32 (6), 801-805, 2021 | 275 | 2021 |
| Correction to:“Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ... Annals of Oncology 30 (5), 871-873, 2019 | 265 | 2019 |
| Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy D Ciardiello, PP Vitiello, C Cardone, G Martini, T Troiani, E Martinelli, ... Cancer treatment reviews 76, 22-32, 2019 | 262 | 2019 |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS K Muro, E Van Cutsem, Y Narita, G Pentheroudakis, E Baba, J Li, MH Ryu, ... Annals of Oncology 30 (1), 19-33, 2019 | 200 | 2019 |
| Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N Stjepanovic, L Moreira, F Carneiro, F Balaguer, A Cervantes, ... Annals of Oncology 30 (10), 1558-1571, 2019 | 194 | 2019 |
| Erlotinib in cancer treatment MA Bareschino, C Schettino, T Troiani, E Martinelli, F Morgillo, ... Annals of oncology 18, vi35-vi41, 2007 | 184 | 2007 |
| Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma F De Vita, M Orditura, E Lieto, S Infusino, F Morgillo, E Martinelli, ... Cancer 100 (2), 270-278, 2004 | 164 | 2004 |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative … LT Chen, E Martinelli, AL Cheng, G Pentheroudakis, S Qin, ... Annals of Oncology 31 (3), 334-351, 2020 | 161 | 2020 |
| Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR–MET interaction and activation of MET signaling in colon cancer cells T Troiani, E Martinelli, S Napolitano, D Vitagliano, LP Ciuffreda, ... Clinical cancer research 19 (24), 6751-6765, 2013 | 157 | 2013 |
| Targeting EGFR in pancreatic cancer treatment T Troiani, E Martinelli, A Capasso, F Morgillo, M Orditura, F De Vita, ... Current drug targets 13 (6), 802-810, 2012 | 154 | 2012 |
| Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives E Martinelli, D Ciardiello, G Martini, T Troiani, C Cardone, PP Vitiello, ... Annals of Oncology 31 (1), 30-40, 2020 | 150 | 2020 |
| Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK E Martinelli, F Morgillo, T Troiani, F Ciardiello Cancer treatment reviews 53, 61-69, 2017 | 148 | 2017 |
